Abstract
IntroductionPerioperative rehabilitation (PORT) has shown a positive effect on patients undergoing cardiac surgery. However, there are minimal data on the impact of short-term PORT in cardiac surgery, which is associated with higher postoperative morbidity and mortality. The trial will assess the efficacy of short-term PORT in reducing in-hospital mortality, postoperative pulmonary complications and length of stay, compared with the usual care in cardiac surgical patients.Methods and analysisThis is a single-centre prospective, randomised, open, controlled trial with a 1:1 ratio. Consecutive 800 adult patients undergoing elective valve surgery will be randomised to either usual care or in-hospital short-term PORT that consists of education, inspiratory muscle training, active cycle of breathing techniques and early mobilisation. The primary outcome of this study will be a composite of in-hospital all-cause mortality, incidence of postoperative pulmonary complications and the ratio of postoperative hospitalisation >7 days.Ethics and disseminationThe PORT study was granted by the Medical Research Ethics Committee of Guangdong Provincial People’s Hospital in August 2018. Findings will be disseminated to patients, clinicians and commissioning groups through peer-reviewed publication.Trial registration numberNCT03709511.
Funder
Natural Science Foundation of Guangdong Province
Guangdong Provincial People's Hospital
Reference52 articles.
1. Global epidemiology of valvular heart disease
2. White book of Chinese cardiovascular surgery and Extracorporeal circulation in 2021;Chin J ECC,2022
3. Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China;Lin;BMC Cardiovasc Disord,2022
4. Validation of the European system for cardiac operative risk evaluation (Euroscore) in Chinese heart valve surgery patients;Wang;J Heart Valve Dis,2010
5. Chinese cardiovascular surgery Registry. is the European system for cardiac operative risk evaluation useful in Chinese patients undergoing heart valve surgery;Zheng;Chin Med J,2012